| Entry |
|
|---|
| Name |
Yttrium Y 90 labetuzumab (USAN);
CES-Cide (TN) |
|---|
| Efficacy |
Antineoplastic, Radioactive agent, Anti-CEA antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Radioimmunotherapy (RAIT) of CEA-expressing tumors for use in the treatment of colorectal cancer
|
|---|
| Target |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: Ig superfamiy
CAMs
CEACAM
D06350 Yttrium Y 90 labetuzumab (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
